ADVERTISEMENT

As monkeypox becomes a global threat, treatment options remain limited

Liz Scherer   |   Clinical Summary   |   02 June 2022
ADVERTISEMENT

Takeaway

  • Monkeypox is an emerging global threat; first-use data suggest that brincidofovir has poor efficacy.

Why this matters

  • Brincidofovir produces reductions in viral PCR cycle thresholds but offers no clinical benefit and is associated with liver function issues.
  • Tecovirimat (2-week course) appears to allow humoral...

          

January Challenge

Ends in 2d 16h
left
right

Topic Challenges

left
right